Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

Clinical trial NCT05269316 · RECRUITING

Trial details

NCT number: NCT05269316
Sponsor: Impact Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Advanced Solid Tumor

Start date: 2022-02-11
Primary completion: 2026-12-31
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.